StockMarketWire.com - Intellectual property investment group Tekcapital said portfolio company Belluscura had filed a broad patent application covering oxygen enrichment inventions.

The patent application, filed in conjunction with research partner Separation Design Group, related to portable artificial lung and wound care devices.

Belluscura chief executive Bob Rauker said the company planned to launch a portable oxygen concentrator later in 2019.


At 9:44am: [LON:TEK] Tekcapital share price was +0.15p at 5.7p



Story provided by StockMarketWire.com